Comparison of the incidence of de novo malignancy in liver or kidney transplant recipients: Analysis of 2673 consecutive cases in a single center

Transplantation Proceedings

Volumn 45, Issue 8, 2013, Pages 3019-3023

  Shin, M ^a   Moon, H H ^a   Kim, J M ^a   Park, J B ^a   Kwon, C H D ^a   Kim, S J ^a   Joh, J W ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; AGE; BRAIN CANCER; BREAST CANCER; CADAVER DONOR; CANCER INCIDENCE; CANCER RISK; CONFERENCE PAPER; DIGESTIVE SYSTEM CANCER; FEMALE; GENDER; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LIVER CANCER; LIVER GRAFT; LIVER GRAFT REJECTION; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEOPLASM; ORGAN TRANSPLANTATION; PANCREAS CANCER; PRIORITY JOURNAL; SKIN CANCER; THYROID CANCER; UROGENITAL TRACT CANCER;

ADULT; FEMALE; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84886257000     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.08.061     Document Type: Conference Paper

References (23)

1. Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011;306:1891.
2. Shimizu T, Hayashi M, Inoue Y, et al. A case of gastric cancer after living donor liver transplantation. Ann Transplant. 2012;17:122.
3. D. Collett, L. Mumford, and N.R. Banner Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit Am J Transplant 10 2010 1889
4. C.M. Vajdic, S.P. McDonald, and M.R. McCredie Cancer incidence before and after kidney transplantation JAMA 296 2006 2823
5. J.I. Herrero De novo malignancies following liver transplantation: impact and recommendations Liver Transpl 15 Suppl 2 2009 S90
6. J.I. Herrero, J.F. Lucena, and J. Quiroga Liver transplant recipients older than 60 years have lower survival and higher incidence of malignancy Am J Transplant 3 2003 1407
7. C.M. Vajdic, and M.T. van Leeuwen Cancer incidence and risk factors after solid organ transplantation Int J Cancer 125 2009 1747
8. Watt KD, Pedersen RA, Kremers WK, et al. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant. 2010;10:1420.
9. X. Xiol, J. Guardiola, and S. Menendez Risk factors for development of de novo neoplasia after liver transplantation Liver Tansp 7 2001 971
10. Chandok N, Watt KD. Burden of de novo malignancy in the liver transplant recipient. Liver Transpl. 2012;18:1277.
11. A.L. Taylor, R. Marcus, and J.A. Bradley Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation Crit Rev Oncol Hematol 56 2005 155
12. J. Dantal, and J.P. Soulillou Immunosuppressive drugs and the risk of cancer after organ transplantation N Engl J Med 352 2005 1371
13. J.J. Fung, A. Jain, and E.J. Kwak De novo malignancies after liver transplantation: a major cause of late death Liver Transpl 7 2001 S109
14. Herrero JI. Screening of de novo tumors after liver transplantation. J Gastroenterol Hepatol. 2012;27:1011.
15. U. Baccarani, G.L. Adani, and D. Montanaro De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases Transplant Proc 38 2006 1135
16. R.T. Bustami, A.O. Ojo, and R.A. Wolfe Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients Am J Transplant 4 2004 87
17. Sampaio MS, Cho YW, Qazi Y, et al. Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National transplant database. Transplantation. 2012;94:990.
18. Watorek E, Boratynska M, Smolska D, et al. Malignancy after renal transplantation in the new era of immunosuppression. Ann Transplant. 2011;16:14.
19. Baccarani U, Piselli P, Serraino D, et al. Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries. Dig Liver Dis. 2010;42:55.
20. A. Jain, V.P. Patil, and J. Fung Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow-up Liver Transpl 14 2008 1406
21. Sapisochin G, Bilbao I, Dopazo C, et al. Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre. Hepatol lnt. 2011;5:707.
22. G.H. Vallejo, C.J. Romero, and J.C. de Vicente Incidence and risk factors for cancer after liver transplantation Crit Rev Oncol Hematol 56 2005 87
23. K.D. Watt, R.A. Pedersen, and W.K. Kremers Long-term probability of and mortality from de novo malignancy after liver transplantation Gastroenterology 137 2009 2010